Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Are you a pumper PT?
View:
Post by losingmyshirt on Mar 25, 2022 11:05am

Are you a pumper PT?

PT, seriously now. No one is buying the Polo22 thing and no believes for a second that you have been speaking to the CEO of Kaly.

Are you taking your meds at the right time? Have you been mixing your meds>?
Comment by Red~One on Mar 25, 2022 11:30am
I might have to take him off ignore, is he losing his shlt again...LOL
Comment by PTBailey on Mar 25, 2022 11:31am
Please leave me on ignore
Comment by PTBailey on Mar 25, 2022 11:31am
Classic case of self-projection. Because you are a dishonest person who hides behind a fake profile and lies to constantly you believe everyone else does what you do.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities